Studies on protective effects of human paraoxonases 1 and 3 on atherosclerosis in apolipoprotein E knockout mice (Q43150774)

14 November 2017

title

Studies on protective effects of human paraoxonases 1 and 3 on atherosclerosis in apolipoprotein E knockout mice (English)

1 reference

14 November 2017

0 references

1 reference

C Zhang

1 reference

14 November 2017

W Peng

1 reference

14 November 2017

M Wang

1 reference

14 November 2017

J Zhu

1 reference

14 November 2017

Y Zang

1 reference

14 November 2017

W Shi

1 reference

14 November 2017

J Zhang

1 reference

14 November 2017

J Qin

1 reference

14 November 2017

language of work or name

1 reference

25 February 2010

1 reference

14 November 2017

1 reference

14 November 2017

1 reference

14 November 2017

1 reference

14 November 2017

page(s)

626-633

1 reference

Cytokines and atherosclerosis: a comprehensive review of studies in mice

14 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.11

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.11

Paraoxonases 1, 2, and 3, oxidative stress, and macrophage foam cell formation during atherosclerosis development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.11

Combined serum paraoxonase knockout/apolipoprotein E knockout mice exhibit increased lipoprotein oxidation and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.11

Structure and evolution of the serum paraoxonase family of detoxifying and anti-atherosclerotic enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.11

Rabbit serum paraoxonase 3 (PON3) is a high density lipoprotein-associated lactonase and protects low density lipoprotein against oxidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.11

Low paraoxonase activity predicts coronary events in the Caerphilly Prospective Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.11

Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.11

Decreased atherosclerotic lesion formation in human serum paraoxonase transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.11

Paraoxonases and cardiovascular diseases: pharmacological and nutritional influences

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.11

Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.11

Human serum paraoxonase 1 decreases macrophage cholesterol biosynthesis: possible role for its phospholipase-A2-like activity and lysophosphatidylcholine formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.11

Decreased obesity and atherosclerosis in human paraoxonase 3 transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.11

The paraoxonase gene family and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.11

Human paraoxonases (PON1, PON2, and PON3) are lactonases with overlapping and distinct substrate specificities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.11

High affinity, stability, and lactonase activity of serum paraoxonase PON1 anchored on HDL with ApoA-I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.11

A role for oxidized phospholipids in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.11

Increased atherosclerosis in mice reconstituted with apolipoprotein E null macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.11

Specific binding of ApoA-I, enhanced cholesterol efflux, and altered plasma membrane morphology in cells expressing ABC1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.11

ABCG1 has a critical role in mediating cholesterol efflux to HDL and preventing cellular lipid accumulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.11

Comparison of the ability of paraoxonases 1 and 3 to attenuate the in vitro oxidation of low-density lipoprotein and reduce macrophage oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.11

Structure-reactivity studies of serum paraoxonase PON1 suggest that its native activity is lactonase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.11

Exclusive expression of transmembrane TNF-alpha in mice reduces the inflammatory response in early lipid lesions of aortic sinus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.11

Disruption of tumor necrosis factor-alpha gene diminishes the development of atherosclerosis in ApoE-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.11

Circulating markers of inflammation and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.11

Genetic alterations of IL-1 receptor antagonist in mice affect plasma cholesterol level and foam cell lesion size

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.11

Interleukin-1 receptor signaling mediates atherosclerosis associated with bacterial exposure and/or a high-fat diet in a murine apolipoprotein E heterozygote model: pharmacotherapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.11

SOCS1 restricts dendritic cells' ability to break self tolerance and induce antitumor immunity by regulating IL-12 production and signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.11

Is raising HDL a futile strategy for atheroprotection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.11

Paraoxonase 1 gene transfer lowers vascular oxidative stress and improves vasomotor function in apolipoprotein E-deficient mice with pre-existing atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.11

Cloning, high level expression of human paraoxonase-3 in Sf9 cells and pharmacological characterization of its product

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.11

Adenovirus-mediated expression of human paraoxonase 3 protects against the progression of atherosclerosis in apolipoprotein E-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.11

7 January 2021

Lack of Interleukin-1β Decreases the Severity of Atherosclerosis in ApoE-Deficient Mice

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.11

7 January 2021

Human PON3, effects beyond the HDL: clues from human PON3 transgenic mice

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.11

7 January 2021

Human paraoxonase-1 overexpression inhibits atherosclerosis in a mouse model of metabolic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.11

7 January 2021

Lysophosphatidylcholine (LPC) attenuates macrophage-mediated oxidation of LDL

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.11

7 January 2021

Molecular regulation of HDL metabolism and function: implications for novel therapies

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.11

7 January 2021

Effect of macrophage-derived mouse ApoE, human ApoE3-Leiden, and human ApoE2 (Arg158-->Cys) on cholesterol levels and atherosclerosis in ApoE-deficient mice

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.11

7 January 2021

Identifiers

DOI

10.1038/GT.2010.11

1 reference

Dimensions Publication ID

14 November 2017

1049564589

0 references

1 reference